IYH vs. XBI
Compare and contrast key facts about iShares U.S. Healthcare ETF (IYH) and SPDR S&P Biotech ETF (XBI).
IYH and XBI are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IYH is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Health Care Index. It was launched on Jun 12, 2000. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006. Both IYH and XBI are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
IYH vs. XBI - Performance Comparison
Loading graphics...
IYH vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IYH iShares U.S. Healthcare ETF | -4.28% | 13.16% | 2.99% | 2.14% | -4.46% | 23.41% | 15.56% | 20.80% | 5.80% | 22.27% |
XBI SPDR S&P Biotech ETF | 5.43% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Returns By Period
In the year-to-date period, IYH achieves a -4.28% return, which is significantly lower than XBI's 5.43% return. Both investments have delivered pretty close results over the past 10 years, with IYH having a 9.51% annualized return and XBI not far behind at 9.39%.
IYH
- 1D
- 0.78%
- 1M
- -5.70%
- YTD
- -4.28%
- 6M
- 3.41%
- 1Y
- 5.26%
- 3Y*
- 5.68%
- 5Y*
- 5.52%
- 10Y*
- 9.51%
XBI
- 1D
- 0.64%
- 1M
- 1.58%
- YTD
- 5.43%
- 6M
- 27.21%
- 1Y
- 65.07%
- 3Y*
- 19.25%
- 5Y*
- -1.16%
- 10Y*
- 9.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IYH vs. XBI - Expense Ratio Comparison
IYH has a 0.43% expense ratio, which is higher than XBI's 0.35% expense ratio.
Return for Risk
IYH vs. XBI — Risk / Return Rank
IYH
XBI
IYH vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Healthcare ETF (IYH) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IYH | XBI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.30 | 2.28 | -1.98 |
Sortino ratioReturn per unit of downside risk | 0.53 | 2.99 | -2.46 |
Omega ratioGain probability vs. loss probability | 1.07 | 1.38 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | 0.32 | 4.41 | -4.09 |
Martin ratioReturn relative to average drawdown | 0.68 | 16.21 | -15.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| IYH | XBI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.30 | 2.28 | -1.98 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | -0.04 | +0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.29 | +0.28 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.36 | +0.07 |
Correlation
The correlation between IYH and XBI is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
IYH vs. XBI - Dividend Comparison
IYH's dividend yield for the trailing twelve months is around 1.30%, more than XBI's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IYH iShares U.S. Healthcare ETF | 1.30% | 1.19% | 1.25% | 1.18% | 1.10% | 0.94% | 1.16% | 1.14% | 1.95% | 1.10% | 1.29% | 2.02% |
XBI SPDR S&P Biotech ETF | 0.34% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Drawdowns
IYH vs. XBI - Drawdown Comparison
The maximum IYH drawdown since its inception was -43.12%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for IYH and XBI.
Loading graphics...
Drawdown Indicators
| IYH | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.12% | -63.89% | +20.77% |
Max Drawdown (1Y)Largest decline over 1 year | -10.52% | -13.39% | +2.87% |
Max Drawdown (5Y)Largest decline over 5 years | -17.91% | -55.04% | +37.13% |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | -63.89% | +35.49% |
Current DrawdownCurrent decline from peak | -7.45% | -25.70% | +18.25% |
Average DrawdownAverage peak-to-trough decline | -8.97% | -20.91% | +11.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.95% | 3.65% | +1.30% |
Volatility
IYH vs. XBI - Volatility Comparison
The current volatility for iShares U.S. Healthcare ETF (IYH) is 4.91%, while SPDR S&P Biotech ETF (XBI) has a volatility of 11.31%. This indicates that IYH experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| IYH | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.91% | 11.31% | -6.40% |
Volatility (6M)Calculated over the trailing 6-month period | 10.32% | 19.25% | -8.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.95% | 28.95% | -11.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.79% | 32.23% | -17.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.70% | 32.15% | -15.45% |